Agilent Technologies Inc (MIL:1A)
€ 122.18 0 (0%) Market Cap: 36.21 Bil Enterprise Value: 37.26 Bil PE Ratio: 28.59 PB Ratio: 6.71 GF Score: 96/100

Agilent Technologies Inc at Goldman Sachs Healthcare Conference Transcript

Jun 13, 2023 / 05:00PM GMT
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

This morning. I'm Matt Sykes, the life sciences tools and diagnostics analyst at Goldman Sachs. It's a pleasure to welcome Bob McMahon, CFO of Agilent to the stage today. Bob, thank you very much for coming.

Robert W. McMahon
Agilent Technologies, Inc. - Senior VP & CFO

Thank you. It's a pleasure to be here.

Questions & Answers

Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

Great. Maybe I'll let you kind of set the stage first and talk about your most recent results and sort of trends you're seeing in your business as we enter the second half of this year.

Robert W. McMahon
Agilent Technologies, Inc. - Senior VP & CFO

Yes. We -- through the first half of the year, we're actually very pleased with the performance of the company. We actually had very solid results in the second quarter, 9.5% core growth and actually 12%

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot